Dr. Liu earned his PhD at Princeton University studying human cytomegalovirus in the laboratory of Dr. Thomas Shenk. His post-doctoral training was at the Icahn School of Medicine at Mount Sinai developing universal influenza vaccine candidates under the guidance of Dr. Peter Palese. He completed his infectious disease fellowship at the Icahn School of Medicine at Mount Sinai. He is an ABIM Board Certified physician in internal medicine and infectious diseases.
Since March 2020, Sean helped to establish the convalescent plasma treatment program at the Mount Sinai Hospital as well as coordinate multiple COVID-19 clinical studies.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Infectious Diseases, ASSOCIATE PROFESSOR | Medicine, Hospital Medicine
Hospital Affiliations
Mount Sinai Queens
The Mount Sinai Hospital
Show More
About Me
Dr. Liu earned his PhD at Princeton University studying human cytomegalovirus in the laboratory of Dr. Thomas Shenk. His post-doctoral training was at the Icahn School of Medicine at Mount Sinai developing universal influenza vaccine candidates under the guidance of Dr. Peter Palese. He completed his infectious disease fellowship at the Icahn School of Medicine at Mount Sinai. He is an ABIM Board Certified physician in internal medicine and infectious diseases.
Since March 2020, Sean helped to establish the convalescent plasma treatment program at the Mount Sinai Hospital as well as coordinate multiple COVID-19 clinical studies.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Infectious Diseases, ASSOCIATE PROFESSOR | Medicine, Hospital Medicine
Hospital Affiliations
Mount Sinai Queens
The Mount Sinai Hospital
Education
MD, Rutgers Robert Wood Johnson Medical School
Residency, Internal Medicine
North Shore University Hospital-Manhasset
Fellowship, Infectious Disease
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Awards
2014
1st Place outstanding poster presentation
North Shore-LIJ Health System Annual Academic Competition – Educational outcomes research
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Liu during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Synairgen
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Show More
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Liu during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Synairgen
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.